PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsAnti-CRISPR - an off-switch for genome editing

BioNews

Anti-CRISPR - an off-switch for genome editing

Published 16 January 2017 posted in News and appears in BioNews 883

Author

Dr Özge Özkaya

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Scientists have discovered a new set of proteins that can block the CRISPR/Cas9 system...

Scientists have discovered a new set of proteins that can block CRISPR/Cas9 , potentially acting as an 'off-switch' for the genome editing system.

'Researchers and the public are reasonably concerned about CRISPR being so powerful that it potentially gets put to dangerous uses,' said Dr Joseph Bondy-Denomy of the University of California, San Francisco, and a senior author of the study. He said that the newly discovered proteins could 'provide a mechanism to block nefarious or out-of-control CRISPR applications, making it safer to explore all the ways this technology can be used to help people'.

The team of researchers had been studying how viruses infect bacteria. They reasoned that in order to incorporate themselves into the genome of the bacteria, some viruses must be able to overcome the CRISPR/Cas9 defence mechanism of the bacteria.

They analysed the genomes of almost 300 strains of Listeria monocytogenes bacteria that had been infected by viruses. Such bacteria were likely to contain viral DNA encoding CRISPR/Cas9-blocking proteins. Dr Bondy-Denomy's team found that more than half of the strains they analysed contained at least one protein capable of blocking CRISPR/Cas9, suggesting that the CRISPR/Cas9 inactivation system is widespread.

Further experiments demonstrated that two of these proteins could inhibit the type of CRISPR/Cas9 system that is now widely used in labs for genome editing bacteria and animal cells.

Based on these findings, the researchers suggest that these inhibitory proteins could help make genome-editing technology safer. The proteins could also be used in newer techniques such as CRISPR interference and CRISPR activation, which are used to increase or decrease gene activity (rather than simply deleting genes).

'The next step is to show in human cells that using these inhibitors can actually improve the precision of genome editing by reducing off-target effects,' said team member Dr Benjamin Rauch, who was first author of the study published in Cell. 'We also want to understand exactly how the inhibitor proteins block Cas9's gene-targeting abilities, and continue the search for more and better CRISPR inhibitors in other bacteria.'

Dr David Edgell from Western University in London, Ontario, who was not involved in the study, told the National Post that it was important to first improve the accuracy of CRISPR/Cas9 before carrying out human genome-editing trials: 'Before you start tweaking the genome of a living person, you want to be assured the gene-editing technology is precise, accurate and not toxic'. 

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
19 July 2018 • 2 minutes read

DNA damage from CRISPR 'seriously underestimated'

by Dr Sam Sherratt

CRISPR/Cas9 genome editing may cause greater genetic damage to cells than previously believed, according to a new study...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
31 July 2017 • 2 minutes read

How new 'molecular scissors' may give crisper CRISPR

by Rikita Patel

Researchers have revealed the structure and action of a new type of 'molecular scissors' known as Cpf1, which may improve CRISPR genome editing.

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
25 November 2016 • 3 minutes read

CRISPR partially restores sight in blind rats

by Paul Waldron

Scientists in the US have used a genome-editing technique to partially restore vision in blind rats...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
14 November 2016 • 2 minutes read

Second team corrects sickle-cell mutation using CRISPR

by Sarah Gregory

Researchers have had further success using the CRISPR/Cas9 genome-editing technique to repair the mutation that causes sickle-cell anaemia...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
19 October 2016 • 2 minutes read

CRISPR success in repairing sickle-cell anaemia mutation

by Sarah Gregory

Researchers have used the CRISPR/Cas9 genome-editing technique to correct the mutation that causes sickle-cell anaemia...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
18 October 2016 • 3 minutes read

CRISPR used to investigate non-coding regions of the genome

by Dr Helen Robertson

Two teams of researchers have used CRISPR genome editing technology to identify 'non-coding' regions of the genome for the first time...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
14 September 2016 • 2 minutes read

CRISPR shrinks tumours in mice

by Dr Özge Özkaya

Scientists from China have managed to shrink the size of tumours in mice using CRISPR/Cas9 genome-editing technology...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Baroness Warnock receives top award in the New Year's Honours List

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

15 August 2022 • 2 minutes read

Call to end ban on HIV-positive partner gamete 'donation'

15 August 2022 • 2 minutes read

Melanoma invades new tissues using nerve cell gene

15 August 2022 • 2 minutes read

Exceeding alcohol limits could damage DNA and accelerate ageing

15 August 2022 • 2 minutes read

Blood cell gene mutations affect mitochondria, increasing cardiovascular disease risk

15 August 2022 • 2 minutes read

Jumping gene helps immune system fight viruses

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856